Speaker illustration

Doctor Peter Liu

University of Ottawa Heart Institute, Ottawa (Canada)

Dr. Peter Liu is the Chief Scientific Officer and VP of Research of the University of Ottawa Heart Institute, and Professor of Medicine and Physiology at the University of Toronto and Ottawa. He is the former Scientific Director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research, and inaugural Director of the Heart & Stroke/Lewar Centre at University of Toronto. He received his MD from U Toronto, and postgraduate training at Harvard University. His laboratory investigates the causes and treatments of heart failure, role of inflammation and identification of novel biomarkers and targets for intervention in cardiovascular diseases. He has published over 430 peer reviewed articles in high impact journals, and received numerous awards. He has chaired scientific sessions of the Heart Failure Society of America, International Society of Heart Research and Human Proteomic Organization, amongst others.

Personalized care of patients with heart failure - REWOLUTION HF international survey on patients' needs and perceptions

Event: Heart Failure 2022

Topic: Treatment

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9


Challenges of integrating omic-derived data.

Event: Heart Failure 2022

Topic: Genetics, Epigenetics, ncRNA

Session: Omics in heart failure: from biomarker to new therapeutic targets


Practical consideration in the decision-making process.

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session: Patient's phenotype at the center of our clinical decisions in heart failure: mission (im)possible?


IGFBP-7: a biomarker of senescence.

Event: Heart Failure 2021

Topic: Biomarkers

Session: New biomarkers for HFpEF phenotyping


Current therapies for heart failure: is there room for improvement?

Event: Heart Failure 2020

Topic: Clinical

Session: Optimizing survival in heart failure: are we doing enough?


Earlier is better: the key role of an early intervention in the heart failure patients

Event: ESC Congress 2019

Topic: Clinical

Session: The heart failure patient's journey: key learning and objectives


Panel discussion about clinical cases - Optimizing the heart failure patients’ pathway right from the discharge.

Event: Heart Failure 2019

Topic: Clinical

Session: Optimizing the heart failure patients’ pathway right from the discharge


Immunosupression: new developments.


Topic: Myocarditis

Session: Myocarditis: update 2016


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb